Korkmaz Murat, Ünal Hakan, Selçuk Haldun, Yilmaz Uğur
Department of Gastroenterology, Başkent University School of Medicine, Ankara.
Turk J Gastroenterol. 2010 Dec;21(4):461-3. doi: 10.4318/tjg.2010.0139.
Carbohydrate antigen 19-9 is most valuable as a serum marker for pancreatic and biliary cancer, but increased concentrations occur in several other gastrointestinal malignancies. A carbohydrate antigen 19-9 value of >1,000 U/ml usually indicates a digestive cancer and has been reported to have a specificity greater than 99% for pancreatic cancer; nevertheless, false-positive results owing to benign diseases such as pancreatitis or liver cirrhosis have been noted. We present a patient with cholelithiasis and choledocholithiasis with acute cholangitis who had very high serum levels of carbohydrate antigen 19-9 (9586 IU/ml). The rapid decrease in carbohydrate antigen 19-9 after successful treatment was as interesting as the pretreatment high serum level of carbohydrate antigen 19-9.
糖类抗原19-9作为胰腺癌和胆管癌的血清标志物最具价值,但在其他几种胃肠道恶性肿瘤中其浓度也会升高。糖类抗原19-9值>1000 U/ml通常提示消化道癌症,据报道其对胰腺癌的特异性大于99%;然而,已注意到胰腺炎或肝硬化等良性疾病会导致假阳性结果。我们报告一例患有胆结石、胆总管结石并伴有急性胆管炎的患者,其血清糖类抗原19-9水平非常高(9586 IU/ml)。成功治疗后糖类抗原19-9的迅速下降与治疗前其血清高水平一样令人关注。